"For purposes of direct comparison, the Prurisol trial outperformed a similarly designed Phase 2b trial in the treatment of mild to moderate psoriasis conducted in 2011 by Anacor Pharmaceuticals in which a topical anti-inflammatory compound was assessed."
Quote:As grotty said, it didn't prove effective in mild, which was the point of the trial.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links